Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

2019 ASH Review of Frontline CLL: Can We Improve CIT by Adding a Novel Agent to the Backbone? How Can Next Generation BTKis Distinguish Themselves from Ibrutinib?

174 views
April 14, 2020
Comments 0
Login to view comments. Click here to Login